|
Match
|
Document |
Document Title |
|
|
US20110195920 |
BIODEFENSES USING TRIAZOLE-CONTAINING MACROLIDES
Use of macrolide and ketolide antibiotics for the treatment of acute exposure and diseases caused by biodefense pathogens is described.
|
|
|
US20090325892 |
Synergistic pesticidal mixtures
Synergistic pesticidal mixtures are provided.
|
|
|
US20120114723 |
ONE STEP FIRE ANT CONTROL
The present invention relates to a method for controlling fire ants with a single step application of a combination of a bait and a controlled release treatment composition, and to the novel...
|
|
|
US20110275582 |
TOPICAL AVERMECTIN FORMULATIONS AND METHODS FOR ELIMINATION AND PROPHYLAXIS OF SUSCEPTIBLE AND TREATMENT RESISTANT STRAINS OF HEAD LICE
An avermectin-based topical formulation is disclosed which is useful for prevention and treatment of head lice (Pediculus humanus capitis). This topical formulation may be formulated as a...
|
|
|
US20120122768 |
ALGINATE OLIGOMERS FOR USE IN OVERCOMING MULTIDRUG RESISTANCE IN BACTERIA
The invention provides a method of overcoming resistance to at least one antibiotic in a multidrug resistant bacterium, said method comprising contacting said bacterium with an alginate oligomer...
|
|
|
US20120121678 |
Vapor-Phase Application Of Spinosyn For The Control Of Pest, And Formulations And Products Utilizing The Same
The present invention relates to the vapor-phase application of at least one spinosyn to treat pests including, for example, vadult mosquitoes and houseflies.
|
|
|
US20120121702 |
Controlled Release Azithromycin Solid Dosage Forms
A solid dosage form for oral administration comprising azithromycin in an amount below that which causes gastrointestinal side effects, which dosage form is a controlled release dosage form.
|
|
|
US20110076261 |
Antifungal Drug Delivery System
A topical treatment for skin disorders and diseases comprising a combination of at least one antifungal agent and at least one hydroxy acid agent having a pH−pKa value of 0.5 or more formulated i...
|
|
|
US20110014204 |
Cancer Chemoprevention Strategy Based on Loss of Imprinting of IGF2
The present invention relates to targets of loss of imprinting (LOI) affected IGF2 gene products in pre-malignant tissues, where methods of inhibiting those targets, including IGFR1, are disclosed...
|
|
|
US20110117153 |
SPINOSYN BAIT FORMULATIONS FOR THE CONTROL OF COCKROACHES AND METHODS OF USING THE SAME
The present invention relates to a pest control product in an ingestible form, comprising at least one active ingredient in need of masking, e.g., spinosyn or derivative or salt thereof, and at...
|
|
|
US20080317857 |
V-Atpase Inhibitors of Use in the Treatment of Septic Shock
The use of vacuolar ATPase inhibitors in the prevention and/or treatment of septic shock is herein described. Vacuolar ATPase inhibitors are selected among products of natural, semi-synthetic or...
|
|
|
US20120115801 |
METHOD FOR OBTAINING A STABLE DISPERSION OF BENZOYL PEROXIDE
Powder containing benzoyl peroxide is readily wetted by contacting the powder with a liquid containing one or more of a polyol, a polyol, ether, and a low-carbon organic alcohol.
|
|
|
US20110281809 |
METHODS AND COMPOSITIONS FOR RAPID TREATMENT OF OTITIS EXTERNA
Methods for treating and preventing otitis externa with a course of treatment consisting of as little as a single dose are provided. The methods are practiced by topical administration of...
|
|
|
US20080081790 |
Azithromycin for the treatment of nodular acne
Azithromycin, administered systemically, is an effective treatment for nodules associated with acne vulgaris.
|
|
|
US20110218165 |
USE OF MACROLIDES IN PEST CONTROL
There is now described a method of controlling pests with macrolide compounds; more specifically A) a method of controlling pests in and on transgenic crops of useful plants, such as, for example,...
|
|
|
US20070142392 |
Uses of rifamycins
The invention features methods, compositions, and kits for treating prosthetic joint infections, foreign body infections, infectious arthritis, and osteomyelitis
|
|
|
US20060073180 |
One step fire ant control
The present invention relates to a method for controlling fire ants with a single step application of a combination of a bait and a controlled release treatment composition, and to the novel...
|
|
|
US20070190188 |
Controlling Toxicity of Aminoquinoline Compounds
A method of controlling toxicity to a user caused by administration to the user of an aminoquinoline compound comprising administering to the user a toxicity controlling amount of at least one...
|
|
|
US20080280840 |
MELOXICAM FOR THE TREATMENT OF RESPIRATORY DISEASES IN PIGS
A method of treating or preventing a respiratory disease in a pig, the method comprising administering to the pig in need thereof an effective amount of meloxicam or a pharmaceutically acceptable...
|
|
|
US20060247184 |
Treatment and prophylaxis of diseases and infections pigs and poultry
The use of AIVLOSIN, as such or as a pharmaceutically acceptable (non-toxic) derivative such as an acid addition salt, for the preparation of a veterinary medicament for the treatment and...
|
|
|
US20070197394 |
Hydrolysis resistant organomodified trisiloxane surfactants
Three types of trisiloxane surfactants having the basic formula: MDM′ are described wherein the substituents on the differing M and M′ groups, in conjunction with pendant polyalkylene oxide sub...
|
|
|
US20110002998 |
PROCESS FOR THE PRODUCTION OF INSECTICIDE-MODIFIED BEAD MATERIAL COMPOSED OF EXPANDABLE POLYSTYRENE AND INSECTICIDE-MODIFIED MOLDINGS OBTAINABLE THEREFROM
A process for the production of insecticide-modified bead material composed of expandable polystyrene (EPS) by extrusion, encompassing the steps of a) mixing, in a mixer, to incorporate a blowing...
|
|
|
US20070010464 |
Avermectin and praziquantel combination therapy
An antiparasitic combination therapy compising a combination of a 13-monosaccharide 5-oxime avermectin, such as selamectin, and praziquantel in a veterinarily acceptable carrier, diluent or...
|
|
|
US20110059136 |
Methods and Compositions for Treating Inflammatory Bowel Disease
The present disclosure provides improved compositions comprising rifabutin, clarithromycin, and clofazimine for use in the treatment of Inflammatory Bowel Diseases. In one instance, the...
|
|
|
US20060171986 |
Antibiotic coating of implants
An antibiotic coating of implants is described, which is characterized in that the coating comprises at least one saturated, organic, hydrophobic, low molecular matrix former whose melting point is...
|
|
|
US20110039794 |
Long Acting Injectable Formulations
Long acting injectable formulations of macrocyclic lactones comprising a biologically acceptable and biodegradable polyester polymer in a solvent system for use in the field of veterinary medicine,...
|
|
|
US20070123476 |
Polyene antibiotic for controlling fungal growth in banana crops
The present invention relates to a process to treat banana plants against disease wherein a polyene antibiotic is applied on the plant. In particular a process is described to protect banana crops...
|
|
|
US20060166905 |
Aivlosin for the treatment of disease due to brachyspira pilosicoli or ornithobacterium rhinotracheale
The invention relates to the use of Aivlosin for the treatment, prevention or control of diseases due to Brachyspira pilosicoli in pigs and Ornithobacterium rhinotrachelae in poultry.
|
|
|
US20050136087 |
Stabilized formulation of ivermectin feed premix with an extended shelf life and method of making the same
The invention relates to a stabilized premix feed or feed-like formulation that has an extended shelf life due to a decrease of the degradates of the active ingredient by controlling the amount of...
|
|
|
US20060093597 |
Methods of treating involuntary facial spasms and facial wrinkles
The invention describes antibiotics, muscle relaxants and plant extracts that have neuromuscular blockade effects as well as methods of use thereof. These compounds can be used in the same clinical...
|
|
|
US20070123477 |
Compositions comprising amphotericin B, methods, and systems
The present invention comprises compositions and formulations comprising amphotericin B, compositions and formulations comprising amphotericin B with one or more excipients, methods of making...
|
|
|
US20050049209 |
Pharmaceutical compositions for delivering macrolides
The present invention provides injectable macrolide oil-in-water emulsions and lyophilized formulations thereof. The present invention also provides methods for preparing and using such...
|
|
|
US20070078057 |
Microemulsion formulation
The present invention provides a storage stable microemulsion formulation for modified lecithin as well as other materials. For modified lecithin, the microemulsion contains at least one metal...
|
|
|
US20070111956 |
Remedy for sarcoidosis and method of treating the same
The present invention provides a remedy for sarcoidosis, one of systemic granulomatous diseases, and a method for treating sarcoidosis. A remedy for sarcoidosis containing a Propionibacterium...
|
|
|
US20090181906 |
Combination Therapies using Melengestrol Acetate and Zilpaterol or its Salts
This invention generally relates to a method for promoting growth and increasing feed utilization efficiency in animals, and, more specifically, to combinations comprising zilpaterol (and salts...
|
|
|
US20110200684 |
SYNERGISTIC PESTICIDAL MIXTURES
Synergistic pesticidal mixtures are provided.
|
|
|
US20080293645 |
Antiparasitic combination and method for treating domestic animals
This invention relates an antiparasitic combination for conveniently treating multiple types of parasites in domestic animals. Specifically, this invention provides a convenient combination and a...
|
|
|
US20080113020 |
SOLID PHARMACEUTICAL COMPOSITION COMPRISING TELITHROMYCIN
The invention relates to a novel solid pharmaceutical composition of telithromycin which facilitates swallowing by the patient.
|
|
|
US20050014706 |
Method of treating tuberculosis
Macrolide and ketolides, and compositions containing the same, useful in the treatment of tuberculosis are disclosed. Methods of treating tuberculosis using the macrolides and ketolides, and...
|
|
|
US20070173462 |
Treatment of diseases associated with the use of antibiotics
This invention relates to the treatment or prevention of diseases associated with the use of antibiotics or cancer chemotherapies or antiviral therapies, such as colitis, pseudomembranous colitis,...
|
|
|
US20070191292 |
Antimycotic rhamnolipid compositions and related methods of use
Antimycotic compositions comprising a rhamnolipid component and related methods of use.
|
|
|
US20050037030 |
Stable topical formulation of clarithromycin
This invention relates to a stable topical formulation of clarithromycin and its use in the treatment of acne.
|
|
|
US20100298247 |
PESTICIDE COMPOSITIONS EXHIBITING ENHANCED ACTIVITY
Pest controlling compositions exhibiting enhanced pesticidal activity levels are disclosed. In one embodiment, a composition includes at least one pesticide, at least one proteinaceous material and...
|
|
|
US20080247985 |
Composition base containing solubilized allantoin and urea for topical preparations
Substantially homogeneous topical preparations for cosmetic, veterinary, and pharmaceutical use comprise at least one active ingredient solubilized in a novel composition base. The composition base...
|
|
|
US20050112165 |
Insect eradication system
An insect pest eradication system comprised of a non-lethal knockout agent selected from cis-1,2-dichloroethylene or trans-1,2-dichloroethylene, and an insecticide.
|
|
|
US20110251067 |
Hydrolysis Resistant Organomodified Trisiloxane Surfactants
Three types of trisiloxane surfactants having the basic formula: MDM′ are described wherein the substituents on the differing M and M′ groups, in conjunction with pendant polyalkylene oxide sub...
|
|
|
US20100323887 |
MESOIONIC PESTICIDES
Disclosed are compounds of Formula 1, wherein X is O or S;Y is O or S;and R1, R2, R3 and R4 are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1...
|
|
|
US20080249033 |
Carbamate Linked Macrolides Useful For The Treatment Of Microbial Infections
The present invention relates to 14- or 15-membered macrolides substituted at the 4″ position of formula (I) and pharmaceutically acceptable derivatives thereof, to processes for their p...
|
|
|
US20080027011 |
Homogeneous paste and gel formulations
This invention provides for a pharmaceutical or veterinary paste or gel formulation which may comprise an effective amount of a therapeutic agent; optionally an absorbent or a viscosity modifier;...
|
|
|
US20070274924 |
Spinosyn fumigants
Methods of controlling arthropod pests by dispersing spinosyn compositions in the form of aerosols, fogs, smokes, or vapors are disclosed.
|